Moneycontrol PRO
ipca laboratories
Jump to
391 Results Found
  • Hold Ipca Laboratories; target of Rs 262: PINC Research Oct 12, 2011 05:31 PM IST

    Hold Ipca Laboratories; target of Rs 262: PINC Research

    PINC Research has maintained hold rating on Ipca Laboratories with a target price of Rs 262 in its October 12, 2011 research report.

  • Tonira Pharma to merge with Ipca Labs; stock up 6% Sep 12, 2011 09:32 AM IST

    Tonira Pharma to merge with Ipca Labs; stock up 6%

    Tonira Pharma will merge with Ipca Laboratories. IPCA currently holds more than 32% on Tonira, reports Business Standard. It touched an intraday high of Rs 25 and an intraday low of Rs 23.50. At 09:30 hrs the share was quoting at Rs 23.85, up Rs 1.35, or 6%.

  • Ipca Labs acquires UK-based Onyx Research Chemicals Aug 09, 2011 04:59 PM IST

    Ipca Labs acquires UK-based Onyx Research Chemicals

    Ipca Laboratories today said its UK subsidiary has acquired Onyx Research Chemicals, the holding company of Onyx Scientific Ltd, a contract manufacturing organisation (CMO) for 4.6 million pounds (nearly Rs 34 crore).

  • Ipca Labs acquires UK-based Onyx Research Chemicals Aug 09, 2011 03:53 PM IST

    Ipca Labs acquires UK-based Onyx Research Chemicals

    Ipca Laboratories today said its UK subsidiary has acquired Onyx Research Chemicals, the holding company of Onyx Scientific Ltd, a contract manufacturing organisation (CMO).

  • Hold IPCA Labs; target of Rs 348: ULJK Securities Jul 11, 2011 11:59 AM IST

    Hold IPCA Labs; target of Rs 348: ULJK Securities

    ULJK Securities has maintained hold rating on IPCA Laboratories with a target price of Rs 348 in its July 7, 2011 research report.

  • Ipca Laboratories expects to clock 18-20% growth in FY12 May 25, 2011 01:26 PM IST

    Ipca Laboratories expects to clock 18-20% growth in FY12

    AK Jain, ED, Ipca Laboratories in an interview with CNBC-TV18 said that the company has projected normal growth of around 18-20% for the whole year. But if it receives the much awaited USFDA approval then it can register much higher growth ahead.

  • IPCA Labs FY11 cons PAT up 28% at Rs 263 cr May 25, 2011 01:17 PM IST

    IPCA Labs FY11 cons PAT up 28% at Rs 263 cr

    IPCA Laboratories has announced FY11 results. The company's FY11 consolidated revenue was up 21% at Rs 1899 crore versus Rs 1567 crore.

  • Expect USFDA nod for Indore unit in three months: Ipca Labs Mar 21, 2011 03:33 PM IST

    Expect USFDA nod for Indore unit in three months: Ipca Labs

    In an interview with CNBC-TV18, AK Jain, ED of Ipca Labs said, "We are waiting for the US FDA to inspect our SEZ Indore plant. This product will be produced there so, till the time we get the approval for the plant we will not be able to take the commercial production of this product."

  • Ipca Laboratories trading firm Mar 21, 2011 10:05 AM IST

    Ipca Laboratories trading firm

    Ipca Laboratories touched an intraday high of Rs 294.50 and an intraday low of Rs 282. At 10:03 hrs the share was quoting at Rs 292.00, up Rs 3.35, or 1.16%.

  • Buy Ipca Laboratories; target of Rs 325: Firstcall Research Mar 14, 2011 12:20 PM IST

    Buy Ipca Laboratories; target of Rs 325: Firstcall Research

    Firstcall Research is bullish on Ipca Laboratories and has recommended buy rating on the stock with a target of Rs 325 in its March 10, 2011 research report.

  • Buy Ipca Laboratories; target of Rs 361: Anagram Research Feb 23, 2011 12:10 PM IST

    Buy Ipca Laboratories; target of Rs 361: Anagram Research

    Anagram Research is bullish on Ipca Laboratories and has recommended buy rating on the stock with a target of Rs 361 in its research report.

  • Buy Ipca Laboratories; target of Rs 360: Sushil Finance Feb 04, 2011 02:01 PM IST

    Buy Ipca Laboratories; target of Rs 360: Sushil Finance

    Sushil Finance is bullish on Ipca Laboratories and has recommended buy rating on the stock with a target of Rs 360 in its January 31, 2011 research report.

  • Ipca Labs Dec '10 sales at Rs 466.36 crore Jan 31, 2011 08:08 PM IST

    Ipca Labs Dec '10 sales at Rs 466.36 crore

    Ipca Laboratories has reported a sales turnover of Rs 466.36 crore and a net profit of Rs 63.95 crore for the quarter ended Dec '10

  • Ipca Labs a market performer; tgt of Rs 332: Karvy Jan 28, 2011 03:47 PM IST

    Ipca Labs a market performer; tgt of Rs 332: Karvy

    Karvy Stock Broking is bullish on Ipca Laboratories and has recommended a market performer rating on the stock with a target of Rs 332 in its January 27, 2011 research report.

  • Ipca Lab Dec qtr PAT seen up 8.8% at Rs 63.4cr: Angel Jan 15, 2011 10:20 AM IST

    Ipca Lab Dec qtr PAT seen up 8.8% at Rs 63.4cr: Angel

    Angel Broking has come out with its earning estimates on the pharmaceutical sector for the quarter ended December 2010. According to the research firm, Ipca Laboratories December quarter net sales are expected to go up by 20.6% to Rs 475 crore, Year-on-Year, (Y-o-Y) basis.

  • Ipca Labs Dec qtr PAT seen up 28.6% at Rs 74.9cr: Karvy Jan 12, 2011 03:55 PM IST

    Ipca Labs Dec qtr PAT seen up 28.6% at Rs 74.9cr: Karvy

    Karvy Stock Broking has come out with its earning estimates on pharma sector for the quarter ended December 2010. According to the research firm, Ipca Laboratories December quarter sales are expected to go up by 18% at Rs 467 crore, Year-on-Year, (YoY) basis.

Sections
ISO 27001 - BSI Assurance Mark